Neurode
PrivateLast Round
Grant
Sep 21, 2025
Total Funding Raised
$5.55M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neurode operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Grant round in September 2025.
Neurode is a healthtech company that develops a wearable headset and accompanying mobile application designed to monitor and treat ADHD symptoms through non-invasive electrical brain stimulation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Consumer Electronics, Health IoT
Business Model
B2C
Customer Profile
Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurode Comparables
Compare Neurode with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mendi Innovations | 82% | |
| Myndlift | 78% | |
| Flow Neuroscience | 77% |
For institutional investors. Book with your work email.
Neurode Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 21, 2025 | ||||
| Pre Seed | Sep 11, 2024 |
For institutional investors. Book with your work email.
Neurode Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Pre Seed |
| SOSV | Accelerator, Pre Seed |
| HAX | Accelerator, Pre Seed |
| Stoic Venture Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 45% MoM.
- May 19, 2026
Monthly visitors increased 87% MoM, reaching 14.8K.
For institutional investors. Book with your work email.
Neurode Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurode's valuation, stock price, and market status.
Is Neurode a public or private company?
Neurode is a private company.
What is the current stock price of Neurode?
Neurode is a private company, so its shares have no public market price. Caplight tracks Neurode's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurode worth (valuation)?
Valuation information for Neurode is not publicly available.
Can I buy Neurode stock?
Neurode shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurode's last funding round?
Neurode's most recent funding round was Grant on September 21, 2025.
Who are the main investors in Neurode?
Key investors in Neurode include Khosla Ventures.
Will Neurode IPO soon?
No public IPO plans have been announced for Neurode.
How can I track Neurode secondary market activity?
Caplight tracks bids, offers, and trades in Neurode's shares on secondary markets.